Literature DB >> 3871442

Normal values for the different classes of venous blood mononuclear cells defined by monoclonal antibodies.

L K Goff, J A Habeshaw, M L Rose, J A Gracie, W Gregory.   

Abstract

We present the data obtained from routine quantitation of normal venous blood mononuclear cells using 19 monoclonal antibodies against defined mononuclear cell surface antigens. The results indicate different values for percentage and absolute numbers of T lymphocytes and of T lymphocyte subsets depending on the monoclonal antibodies used to quantify these populations. In most instances the total number of identified cells was significantly less than the total number of recovered blood mononuclear cells, which suggests the existence in blood of a null cell population. Evidence is advanced to support previous observations that at least a proportion of this population is of B cell lineage, expressing cytoplasmic immunoglobulin but lacking other class or lineage specific markers. The value of a diverse monoclonal panel in routine quantitation of peripheral blood mononuclear cells is discussed.

Mesh:

Substances:

Year:  1985        PMID: 3871442      PMCID: PMC499071          DOI: 10.1136/jcp.38.1.54

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

3.  Quantitation of subclasses of mononuclear cells in normal human blood by membrane receptor studies.

Authors:  J A Habeshaw; G A Young
Journal:  Br J Haematol       Date:  1975-01       Impact factor: 6.998

4.  Phenotypes of 'null' lymphoid cells in human blood.

Authors:  P Niaudet; M Greaves; D Horwitz
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

5.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

6.  A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

Authors:  C S Abramson; J H Kersey; T W LeBien
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.

Authors:  A C Aisenberg
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

8.  Isolation of human haematopoietic progenitor cells using monoclonal antibodies.

Authors:  P C Beverley; D Linch; D Delia
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

9.  Antigens on human monocytes identified by monoclonal antibodies.

Authors:  R F Todd; L M Nadler; S F Schlossman
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  3 in total

1.  Lymphocyte surface marker studies in the diagnosis of unexplained lymphocytosis.

Authors:  M C Quantz; J B Robinson; V Sachs; P H Pinkerton
Journal:  CMAJ       Date:  1987-04-15       Impact factor: 8.262

2.  Two-colour immunoenzymatic technique using sequential staining by APAAP to evaluate two cell antigens.

Authors:  R Burgess; K Hyde; P J Maguire; P R Kelsey; J A Yin; C G Geary
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

3.  T cell subset profile in healthy Zambian adults at the University Teaching Hospital.

Authors:  Caroline Cleopatra Chisenga; Paul Kelly
Journal:  Pan Afr Med J       Date:  2016-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.